|
Re: RVX Current Status
|
9
|
Resverlogix Corp.
|
Feb 28, 2020 10:18AM
|
|
Re: FDA greenlights Eli Lilly COVID-19 combo therapy
|
9
|
Resverlogix Corp.
|
Mar 10, 2021 08:23PM
|
|
Re: Article
|
9
|
Resverlogix Corp.
|
May 29, 2022 04:26PM
|
|
Re: Forest plot
|
9
|
Resverlogix Corp.
|
Nov 16, 2019 12:55PM
|
|
Re: Kidney data rocks!
|
9
|
Resverlogix Corp.
|
Nov 16, 2019 01:17PM
|
|
Re: when Don said this might slide into April
|
9
|
Resverlogix Corp.
|
Mar 30, 2021 05:07PM
|
|
Meaning of MACE in the BTD
|
9
|
Resverlogix Corp.
|
Feb 18, 2020 07:30PM
|
|
Re: Finance
|
9
|
Resverlogix Corp.
|
May 25, 2020 05:48PM
|
|
Re: Revised target market, indications, market potential? ... and some numbers?
|
9
|
Resverlogix Corp.
|
Jun 13, 2020 05:15PM
|
|
Re: My Non-Scientific Net-Net Preliminary Conclusions
|
9
|
Resverlogix Corp.
|
Nov 16, 2019 02:42PM
|
|
Secondary endpoints
|
8
|
Resverlogix Corp.
|
Oct 11, 2019 02:13PM
|
|
Re: Take Home Points: not ready for use in patients
|
8
|
Resverlogix Corp.
|
Nov 16, 2019 04:26PM
|
|
Youtube interview at AHA - Dr Ray
|
8
|
Resverlogix Corp.
|
Nov 16, 2019 06:00PM
|
|
New patent
|
8
|
Resverlogix Corp.
|
Nov 03, 2019 08:27AM
|
|
Re: Resverlogix Announces Topline Results in BETonMACE Phase 3 Epigenetics Trial
|
8
|
Resverlogix Corp.
|
Sep 30, 2019 02:28PM
|
|
Re: Thinking back on an older discussion and wishing we had an update - Few items
|
8
|
Resverlogix Corp.
|
Jul 26, 2020 07:10PM
|
|
Re: Thrown in the towel?
|
8
|
Resverlogix Corp.
|
Aug 01, 2022 04:04PM
|
|
Re: Future Trials
|
8
|
Resverlogix Corp.
|
Feb 14, 2020 02:45PM
|
|
Re: U of A
|
8
|
Resverlogix Corp.
|
Oct 26, 2021 06:28PM
|
|
Epigenetics, CHF, and ABL
|
8
|
Resverlogix Corp.
|
Dec 20, 2019 03:13PM
|
